Floquet control uses time-periodic drives to engineer quantum systems, creating dynamic changes in material properties ...
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, January 7, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a ...
Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart failure with preserved ejection fraction (HFpEF) ...
Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...
Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...
The new Harley-Davidson X440 T, built at Hero’s Neemrana plant, is a motorcycle that can take the rough with the smooth ...
Ad Hoc Announcement Pursuant to Art.?53 LR Geneva, Switzerland, January 7, 2026 - Addex Therapeutics(SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing ...
The Phase 1b trial consisted of 24 patients with Parkinson’s disease, who received twice-weekly dosing of either HER-096 or placebo over a four-week period. The trial’s exploratory biomarker program ...
A chip smaller than one square millimeter stores 160 holographic images at arbitrary 3D coordinates, with each spatial ...
Seasoned executive with extensive board experience across US and European biotechnology companiesBrings extensive operational, strategic and transactional ...
Driven by the global wave of informatization, the real-time transmission, efficient processing, and intelligent analysis of massive data have become ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback